RESEARCH ON PROSTATE CANCER>

Metabolic syndrome increases risk for prostate and other cancers and it also
inhibits PSA levels which have to be interpreted in a different way, with lower
levels of PSA indicating possible disease in men with this syndrome.

PSA screening may cause psychological harms, and its benefits are uncertain.

Stress-related psychological factors may increase cancer rates and cancer death
rates, and decrease survival times.

Certain interpersonal styles, specifically interpersonal sensitivity may complicate
the recovery of sexual function after radical prostatectomy for prostate cancer.

To improve the experience of prostate cancer care for patients, health care
providers should identify and respond to each individual’s information needs and
preferences regarding decision-making.

There was some preventive benefit for the men taking soy protein in this study.

Soy protein isolate reduces androgen expression in the prostate, which may help
prevent prostate cancer.

Soy protein supplementation may benefit men at risk of developing advanced
prostate cancer.

Long-term vitamin E supplementation may reduce risk of advanced prostate
cancer.

A ‘male lumpectomy’ can successfully treat some prostate cancers, while
preserving urinary continence and sexual potency.

Prostate cancer patients treatments choices are determined by physician specialty
rather than patient preference.

Men who have had EBRT end up with a higher incidence of urinary and
gastrointestinal symptoms than other men of the same age.

From.........Inspire Health Research Summaries, Vancouver, B.C.